KELVIN MEDICAL, INC. (KVMD) financial statements (2021 and earlier)

Company profile

Business Address 10930 SKYRANCH PLACE
NEVADA CITY, NV 95959
State of Incorp. NV
Fiscal Year End June 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2018
Q3
12/31/2017
Q2
9/30/2017
Q1
6/30/2017
Q4
3/31/2017
Q3
12/31/2016
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments378561791
Cash and cash equivalents378561791
Receivables  333 
Prepaid expense 2    
Deferred costs    6060
Other undisclosed current assets     3
Total current assets:37879207264
Noncurrent Assets
TOTAL ASSETS:37879207264
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities559536
Accounts payable55953 
Employee-related liabilities     6
Due to related parties596555
Customer advances and deposits00000 
Other undisclosed current liabilities33282119246
Total current liabilities:434336293317
Noncurrent Liabilities
Total liabilities:434336293317
Stockholders' equity
Stockholders' equity attributable to parent, including:(6)44(27)(9)3947
Common stock   646363
Additional paid in capital17016578785757
Accumulated deficit(243)(188)(169)(151)(81)(73)
Other undisclosed stockholders' equity attributable to parent676764   
Total stockholders' equity:(6)44(27)(9)3947
TOTAL LIABILITIES AND EQUITY:37879207264

Income statement (P&L) ($ in thousands)

3/31/2018
Q3
12/31/2017
Q2
9/30/2017
Q1
6/30/2017
Q4
3/31/2017
Q3
12/31/2016
Q2
Gross profit:(2)(2)    
Operating expenses(55)(19)(18)(70)(8)(5)
Other undisclosed operating income22    
Operating loss:(55)(19)(18)(70)(8)(5)
Net loss available to common stockholders, diluted:(55)(19)(18)(70)(8)(5)

Comprehensive Income ($ in thousands)

3/31/2018
Q3
12/31/2017
Q2
9/30/2017
Q1
6/30/2017
Q4
3/31/2017
Q3
12/31/2016
Q2
Net loss:(55)(19)(18)(70)(8)(5)
Comprehensive loss, net of tax, attributable to parent:(55)(19)(18)(70)(8)(5)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: